Coronavirus

The National Association of Boards of Pharmacy Passport is a temporary authorization that facilitates pharmacists and pharmacy technicians practicing in another state.

Pharmacists can play an important role in educating patients about poison prevention tips during the pandemic, and discuss the dangers of home remedies.

A recent study has detailed information on the potential dangers and the application of QTc monitoring to guide treatment when using drugs that can cause heart rhythm changes.

The length of time patients remained contagious after the end of their symptoms, however, ranged from 1 to 8 days.

"We are trying to stay strong, and we couldn’t cope with this situation if it wasn’t for our deep team connection.”

While the drugs are not currently FDA-approved for COVID-19, the FDA noted that they are recommended in some countries for COVID-19.

Members of the Society of Infectious Diseases Pharmacists (SIDP) have been on the forefront of the pandemic, reviewing treatment data and assisting in interpretation for clinical use.

How has COVID-19 affected our lives?

In the midst of rapid industry changes and new demands brought by the coronavirus disease 2019 pandemic, pharmacy technicians are taking on new roles and responsibilities.

According to the researchers, the case fatality rate for patients with COVID-19 and cardiovascular disease is 10.5%.

Other therapeutic possibilities include a combination of HIV-1 protease inhibitors.

Following the precautions many grocery stores across the nation have taken, various pharmacies in the United States are altering their hours and other services to cater to high-risk and senior citizen shoppers due to concerns surrounding the coronavirus disease 2019 (COVID-19) spread.

Today we’re celebrating 3 pharmacists for their amazing work organizing a drive-through testing center.

The letter was issued by the American Pharmacists Association, the Alliance for Pharmacy Compounding, the National Community Pharmacists Association, and the National Alliance of State Pharmacy Associations.

During the COVID-19 pandemic, pharmacists are concerned not only about shortages in drugs that could treat the virus, but also medications for managing other conditions.

The waivers were approved within days of the states' submissions.

Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.

Today’s pharmacy hero is Diane Berkley, CPhT. In addition to working full time at a local hospital during the day, Berkley also works part-time at a community pharmacy.

The FDA has issued a statement regarding action to help increase the supply of ventilators, ventilator tubing connectors, and ventilator accessories during the COVID-19 pandemic.

More than 60 front-end, nonprescription products are currently available for purchase at drive-thru windows.

The researchers noted that it is still important for people to cover their eyes, hands, and mouth to avoid virus particles spread from another person.

More than 1800 members registered for the town hall-style meeting, during which Rep. Buddy Carter (R-GA), a pharmacist and congressman, briefed attendees about emergency relief efforts currently in development by policymakers, efforts to address pharmacy direct and indirect remuneration (DIR) fees, and other key issues.

According to reporting by NPR, the decision may be in response to backlash from the health care community

For specialty pharmacies, contingency plans for COVID-19 are not as simple as moving a workforce to their remote access solutions.

Today we're thanking a pharmacist who has spent over 30 years caring for his community in New Jersey.

CVS Health said it has implemented new protocols to continue to combat the pandemic and to protect the health of their employees.

These professional organizations are aware that some medications are being prophylactically prescribed as potential treatments for COVID-19.

Ben Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.

The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.